Your browser doesn't support javascript.
loading
Nasal allergen challenge and environmental exposure chamber challenge: A randomized trial comparing clinical and biological responses to cat allergen.
Larson, David; Patel, Piyush; Salapatek, Anne Marie; Couroux, Peter; Whitehouse, Don; Pina, Adela; Johnson, Jacqueline L; Sever, Michelle L; Sanda, Srinath; Poyser, Julian; Allio, Theresa; Scadding, Guy W; Qin, Tielin; Shamji, Mohamed H; Kwok, William W; James, Eddie A; French, Deanna; Lelic, Alina; Larché, Mark; Altman, Matthew C; Togias, Alkis; Durham, Stephen R.
Afiliação
  • Larson D; The Immune Tolerance Network, Bethesda, Md. Electronic address: dlarson@immunetolerance.org.
  • Patel P; Inflamax Research Limited, DBA Cliantha Research, Mississauga, Canada.
  • Salapatek AM; Inflamax Research Limited, DBA Cliantha Research, Mississauga, Canada.
  • Couroux P; Inflamax Research Limited, DBA Cliantha Research, Mississauga, Canada.
  • Whitehouse D; Immune Tolerance Network, San Francisco, Calif.
  • Pina A; Rho Federal Systems Division, Durham, NC.
  • Johnson JL; Rho Federal Systems Division, Durham, NC.
  • Sever ML; Rho Federal Systems Division, Durham, NC.
  • Sanda S; Immune Tolerance Network, San Francisco, Calif.
  • Poyser J; National Institute of Allergy and Infectious Diseases, Bethesda, Md.
  • Allio T; National Institute of Allergy and Infectious Diseases, Bethesda, Md.
  • Scadding GW; MRC and Asthma UK, Centre in Allergic Mechanisms of Asthma, London, United Kingdom.
  • Qin T; The Immune Tolerance Network, Bethesda, Md.
  • Shamji MH; MRC and Asthma UK, Centre in Allergic Mechanisms of Asthma, London, United Kingdom; Immunomodulation and Tolerance Group, Allergy and Clinical Immunology, Section of Inflammation Repair and Development, National Heart and Lung Institute, Imperial College London, London, United Kingdom.
  • Kwok WW; Benaroya Research Institute, Department of Translational Research, Seattle, Wash.
  • James EA; Benaroya Research Institute, Department of Translational Research, Seattle, Wash.
  • French D; McMaster University, Hamilton, Ontario, Canada.
  • Lelic A; Human Immunology Testing Suite, McMaster University, Hamilton, Ontario, Canada.
  • Larché M; McMaster University, Hamilton, Ontario, Canada; Divisions of Clinical Immunology & Allergy and Respirology, Department of Medicine, Firestone Institute of Respiratory Health, The Research Institute, St Joe's Hamilton, Hamilton, Canada.
  • Altman MC; Department of Medicine, University of Washington, Seattle, Wash; Benaroya Research Institute, Systems Immunology Division, Seattle, Wash.
  • Togias A; National Institute of Allergy and Infectious Diseases, Bethesda, Md.
  • Durham SR; MRC and Asthma UK, Centre in Allergic Mechanisms of Asthma, London, United Kingdom; Immunomodulation and Tolerance Group, Allergy and Clinical Immunology, Section of Inflammation Repair and Development, National Heart and Lung Institute, Imperial College London, London, United Kingdom.
J Allergy Clin Immunol ; 145(6): 1585-1597, 2020 06.
Article em En | MEDLINE | ID: mdl-32169380
ABSTRACT

BACKGROUND:

The direct-instillation nasal allergen challenge (NAC) and the environmental exposure chamber (EEC) are 2 methods of conducting controlled allergen provocations. The clinical and biological comparability of these methods has not been thoroughly investigated.

OBJECTIVE:

We sought to compare clinical and immunologic responses to cat allergen in NAC versus EEC.

METHODS:

Twenty-four participants were randomized to receive either NAC followed by a 2-day challenge in an EEC or a 2-day challenge in an EEC followed by NAC. Challenges were separated by 28-day washout periods. We measured total nasal symptom scores, peak nasal inspiratory flow, nasal (0-8 hours) and serum cytokines, serum antibodies, peripheral blood antigen-specific T lymphocytes, and gene expression in nasal scrapings. The primary outcome was the total nasal symptom score area under the curve for the first 3 hours after allergen exposure in NAC or after initiation of exposure in EEC.

RESULTS:

Both challenges increased IL-5 and IL-13 in nasal fluids and serum and resulted in altered nasal cell expression of gene modules related to mucosal biology and transcriptional regulation. Changes in gene modules, more so than cytokine measurements, showed significant associations with total nasal symptom score and peak nasal inspiratory flow. Overall, EEC exposure generated larger responses and more early terminations compared with NAC. Although the 2 challenges did not correlate in symptom magnitude or temporality, striking correlations were observed in cytokine levels.

CONCLUSIONS:

Although clinical outcomes of NAC and EEC were temporally different and nonequivalent in magnitude, immunologic responses were similar. Selection of a particular allergen challenge method should depend on considerations of study objectives and cost.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 2_ODS3 Problema de saúde: 2_quimicos_contaminacion Assunto principal: Alérgenos / Gatos / Exposição Ambiental / Mucosa Nasal Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Animals / Female / Humans / Male / Middle aged Idioma: En Revista: J Allergy Clin Immunol Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 2_ODS3 Problema de saúde: 2_quimicos_contaminacion Assunto principal: Alérgenos / Gatos / Exposição Ambiental / Mucosa Nasal Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Animals / Female / Humans / Male / Middle aged Idioma: En Revista: J Allergy Clin Immunol Ano de publicação: 2020 Tipo de documento: Article
...